Publications by authors named "Szeman Ruby Chan"

Claim this Profile
A
A stable, engineered TL1A ligand co-stimulates T cells via specific binding to DR3.
Adam Zwolak, Szeman Ruby Chan, Paul Harvilla, Sally Mahady, Anthony A Armstrong

Sci Rep· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hyper-Activation of STAT3 Sustains Progression of Non-Papillary Basal-Type Bladder Cancer via FOSL1 Regulome.
Luisa Benerini Gatta, Laura Melocchi, Mattia Bugatti, Francesco Missale, Silvia Lonardi, Szeman Ruby Chan

Cancers (Basel)· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sex as a Biologic Variable in Preclinical Imaging Research: Initial Observations with F-FLT.
Szeman Ruby Chan, Kelley Salem, Justin Jeffery, Ginny L Powers, Yongjun Yan

J Nucl Med· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity.
Karla R Wiehagen, Natasha M Girgis, Douglas H Yamada, Andressa A Smith, Szeman Ruby Chan

Cancer Immunol Res· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Truncating Prolactin Receptor Mutations Promote Tumor Growth in Murine Estrogen Receptor-Alpha Mammary Carcinomas.
Obi L Griffith, Szeman Ruby Chan, Malachi Griffith, Kilannin Krysiak, Zachary L Skidmore

Cell Rep· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel ERα positive breast cancer model with estrogen independent growth in the bone microenvironment.
Aude-Hélène Capietto, Szeman Ruby Chan, Biancamaria Ricci, Julie A Allen, Xinming Su

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal noninvasive imaging of progesterone receptor as a predictive biomarker of tumor responsiveness to estrogen deprivation therapy.
Szeman Ruby Chan, Amy M Fowler, Julie A Allen, Dong Zhou, Carmen S Dence

Clin Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying the initiating events of anti-Listeria responses using mice with conditional loss of IFN-γ receptor subunit 1 (IFNGR1).
Sang Hun Lee, Javier A Carrero, Ravindra Uppaluri, J Michael White, Jessica M Archambault, Szeman Ruby Chan

J Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using a preclinical model of breast cancer.
Amy M Fowler, Szeman Ruby Chan, Terry L Sharp, Nicole M Fettig, Dong Zhou

J Nucl Med· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STAT1-deficient mice spontaneously develop estrogen receptor α-positive luminal mammary carcinomas.
Szeman Ruby Chan, William Vermi, Jingqin Luo, Laura Lucini, Charles Rickert

Breast Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis